Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 3
2018 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
Harjola VP, Lassus J, Sionis A, Køber L, Tarvasmäki T, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Di Somma S, Tolppanen H, Zeymer U, Thiele H, Nieminen MS, Mebazaa A; CardShock Study Investigators; GREAT network. Harjola VP, et al. Eur J Heart Fail. 2015 May;17(5):501-9. doi: 10.1002/ejhf.260. Epub 2015 Mar 28. Eur J Heart Fail. 2015. PMID: 25820680 Free article.
Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality.
Tarvasmäki T, Haapio M, Mebazaa A, Sionis A, Silva-Cardoso J, Tolppanen H, Lindholm MG, Pulkki K, Parissis J, Harjola VP, Lassus J; CardShock Study Investigators. Tarvasmäki T, et al. Eur J Heart Fail. 2018 Mar;20(3):572-581. doi: 10.1002/ejhf.958. Epub 2017 Sep 27. Eur J Heart Fail. 2018. PMID: 28960633 Free article. Clinical Trial. No abstract available.
Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock.
Jäntti T, Tarvasmäki T, Harjola VP, Pulkki K, Turkia H, Sabell T, Tolppanen H, Jurkko R, Hongisto M, Kataja A, Sionis A, Silva-Cardoso J, Banaszewski M, DiSomma S, Mebazaa A, Haapio M, Lassus J; CardShock investigators. Jäntti T, et al. Ann Intensive Care. 2021 Feb 5;11(1):25. doi: 10.1186/s13613-021-00814-8. Ann Intensive Care. 2021. PMID: 33547528 Free PMC article.
Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock.
Jäntti T, Tarvasmäki T, Harjola VP, Parissis J, Pulkki K, Sionis A, Silva-Cardoso J, Køber L, Banaszewski M, Spinar J, Fuhrmann V, Tolonen J, Carubelli V, diSomma S, Mebazaa A, Lassus J; CardShock investigators. Jäntti T, et al. Am J Cardiol. 2017 Oct 1;120(7):1090-1097. doi: 10.1016/j.amjcard.2017.06.049. Epub 2017 Jul 14. Am J Cardiol. 2017. PMID: 28821350
Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome.
Tolppanen H, Rivas-Lasarte M, Lassus J, Sadoune M, Gayat E, Pulkki K, Arrigo M, Krastinova E, Sionis A, Parissis J, Spinar J, Januzzi J, Harjola VP, Mebazaa A; CardShock Investigators. Tolppanen H, et al. Crit Care Med. 2017 Jul;45(7):e666-e673. doi: 10.1097/CCM.0000000000002336. Crit Care Med. 2017. PMID: 28403119
Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
Tarvasmäki T, Lassus J, Varpula M, Sionis A, Sund R, Køber L, Spinar J, Parissis J, Banaszewski M, Silva Cardoso J, Carubelli V, Di Somma S, Mebazaa A, Harjola VP; CardShock study investigators. Tarvasmäki T, et al. Crit Care. 2016 Jul 4;20(1):208. doi: 10.1186/s13054-016-1387-1. Crit Care. 2016. PMID: 27374027 Free PMC article.